$211 Million is the total value of Tamarack Advisers, LP's 49 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 70.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Buy | CIGNA CORPequity | $17,971,000 | +878.3% | 75,000 | +837.5% | 8.50% | +1026.2% |
| PCRX | Sell | PACIRA BIOSCIENCES INCequity | $15,646,000 | +8.3% | 205,000 | -14.6% | 7.40% | +24.7% |
| LNTH | Sell | LANTHEUS HOLDINGS INCequity | $13,828,000 | +34.8% | 250,000 | -29.6% | 6.54% | +55.2% |
| MRK | Buy | MERCK & CO. INC.equity | $12,718,000 | +137.1% | 155,000 | +121.4% | 6.02% | +172.8% |
| BVS | Sell | BIOVENTUS INC - Aequity | $11,633,000 | -8.2% | 825,001 | -5.7% | 5.50% | +5.6% |
| SIBN | Sell | SI-BONE INCequity | $10,735,000 | -12.1% | 475,000 | -13.6% | 5.08% | +1.1% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INCequity | $9,718,000 | -18.5% | 3,250,000 | -27.8% | 4.60% | -6.2% |
| CERS | Buy | CERUS CORPequity | $9,059,000 | +33.0% | 1,650,000 | +65.0% | 4.29% | +53.1% |
| MDT | Sell | MEDTRONIC PLCequity | $8,321,000 | -35.7% | 75,000 | -40.0% | 3.94% | -26.0% |
| ANGO | Sell | ANGIODYNAMICS INCequity | $6,893,000 | -27.6% | 320,000 | -7.2% | 3.26% | -16.6% |
| TPB | Sell | TURNING POINT BRANDS INCequity | $6,802,000 | -28.0% | 200,000 | -20.0% | 3.22% | -17.1% |
| New | PERRIGO CO PLCequity | $6,725,000 | – | 175,000 | +100.0% | 3.18% | – | |
| THC | Sell | TENET HEALTHCARE CORPequity | $6,447,000 | -60.5% | 75,000 | -62.5% | 3.05% | -54.6% |
| ISEE | Buy | IVERIC BIO INCequity | $6,227,000 | +65.5% | 370,000 | +64.4% | 2.95% | +90.4% |
| CVS | Buy | CVS HEALTH CORPequity | $5,061,000 | +22.7% | 50,000 | +25.0% | 2.40% | +41.2% |
| INMD | Buy | INMODE LTDequity | $4,798,000 | +51.1% | 130,000 | +188.9% | 2.27% | +73.8% |
| New | JAZZ PHARMACEUTICALS PLCequity | $4,670,000 | – | 30,000 | +100.0% | 2.21% | – | |
| PHR | Buy | PHREESIA INCequity | $4,613,000 | +47.6% | 175,000 | +133.3% | 2.18% | +69.9% |
| EXEL | New | EXELIXIS INCequity | $4,534,000 | – | 200,000 | +100.0% | 2.14% | – |
| MDRX | ALLSCRIPTS HEALTHCARE SOLUTIequity | $4,504,000 | +22.1% | 200,000 | 0.0% | 2.13% | +40.5% | |
| GILD | New | GILEAD SCIENCES INCequity | $4,459,000 | – | 75,000 | +100.0% | 2.11% | – |
| HSIC | Buy | HENRY SCHEIN INCequity | $4,360,000 | +52.0% | 50,000 | +35.1% | 2.06% | +74.8% |
| ATRC | Sell | ATRICURE INCequity | $4,269,000 | -38.6% | 65,000 | -35.0% | 2.02% | -29.3% |
| TCMD | New | TACTILE SYSTEMS TECHNOLOGY Iequity | $2,475,000 | – | 122,756 | +100.0% | 1.17% | – |
| VTRS | Sell | VIATRIS INCequity | $2,448,000 | -63.8% | 225,000 | -55.0% | 1.16% | -58.4% |
| VRAY | Sell | VIEWRAY INCequity | $2,352,000 | -64.4% | 600,000 | -50.0% | 1.11% | -59.1% |
| Buy | SOMALOGIC INCwarrant | $2,249,000 | +28.8% | 295,000 | +96.7% | 1.06% | +48.2% | |
| CVET | New | COVETRUS INCequity | $2,166,000 | – | 129,000 | +100.0% | 1.02% | – |
| UNH | Buy | UNITEDHEALTH GROUP INCequity | $2,040,000 | +306.4% | 4,000 | +300.0% | 0.96% | +368.4% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCequity | $2,033,000 | – | 125,000 | +100.0% | 0.96% | – |
| SPY | New | SPY US 04/14/22 P440put | $1,807,000 | – | 4,000 | +100.0% | 0.86% | – |
| PDCO | Sell | PATTERSON COS INCequity | $1,619,000 | -44.8% | 50,000 | -50.0% | 0.77% | -36.5% |
| HOLX | New | HOLOGIC INCequity | $1,152,000 | – | 15,000 | +100.0% | 0.54% | – |
| RDNT | Sell | RADNET INCequity | $1,119,000 | -66.2% | 50,000 | -54.5% | 0.53% | -61.2% |
| TCNNF | Sell | TRULIEVE CANNABIS CORPequity | $1,053,000 | -52.4% | 50,000 | -41.2% | 0.50% | -45.2% |
| NXGN | New | NEXTGEN HEALTHCARE INCequity | $1,046,000 | – | 50,000 | +100.0% | 0.50% | – |
| New | DOCGO INCequity | $1,018,000 | – | 110,000 | +100.0% | 0.48% | – | |
| New | DERMTECH INCequity | $734,000 | – | 50,000 | +100.0% | 0.35% | – | |
| Sell | VERANO HOLDINGS CORPequity | $497,000 | -47.4% | 50,000 | -33.3% | 0.24% | -39.4% | |
| Sell | TERRASCEND CORPequity | $428,000 | -53.3% | 75,000 | -50.0% | 0.20% | -46.2% | |
| PLXS | Sell | PLEXUS CORPequity | $409,000 | -89.8% | 5,000 | -88.1% | 0.19% | -88.3% |
| AHCO | Sell | ADAPTHEALTH CORPequity | $321,000 | -89.5% | 20,000 | -84.0% | 0.15% | -87.9% |
| GLD | New | GLD US 06/17/22 C180call | $181,000 | – | 1,000 | +100.0% | 0.09% | – |
| CVS | New | CVS US 04/01/22 P101put | $101,000 | – | 1,000 | +100.0% | 0.05% | – |
| BAX | New | BAX US 05/20/22 P75put | $78,000 | – | 1,000 | +100.0% | 0.04% | – |
| VTRS | New | VTRS US 04/14/22 C15call | $33,000 | – | 3,000 | +100.0% | 0.02% | – |
| Exit | RIGL US 01/21/22 C10call | $0 | – | -5,705 | -100.0% | -0.01% | – | |
| Exit | VTRS US 01/21/22 C15call | $0 | – | -10,000 | -100.0% | -0.02% | – | |
| Exit | CM LIFE SCIENCES II -CW27warrant | $0 | – | -20,000 | -100.0% | -0.03% | – | |
| PRGO | Exit | PERRIGO CO PLCequity | $0 | – | -10,000 | -100.0% | -0.16% | – |
| Exit | IWM US 02/18/22 P215put | $0 | – | -1,000 | -100.0% | -0.18% | – | |
| Exit | TDOC US 01/21/22 P115put | $0 | – | -250 | -100.0% | -0.24% | – | |
| GTBIF | Exit | GREEN THUMB INDUSTRIES INCequity | $0 | – | -75,000 | -100.0% | -0.68% | – |
| ITGR | Exit | INTEGER HOLDINGS CORPequity | $0 | – | -25,000 | -100.0% | -0.88% | – |
| XBI | Exit | SPDR S&P BIOTECH ETFexchange traded fund | $0 | – | -25,000 | -100.0% | -1.15% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLCequity | $0 | – | -25,000 | -100.0% | -1.31% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORPequity | $0 | – | -15,000 | -100.0% | -1.33% | – |
| BAX | Exit | BAXTER INTERNATIONAL INCequity | $0 | – | -50,000 | -100.0% | -1.76% | – |
| SMG | Exit | SCOTTS MIRACLE-GRO COequity | $0 | – | -30,000 | -100.0% | -1.99% | – |
| MCK | Exit | MCKESSON CORPequity | $0 | – | -20,000 | -100.0% | -2.04% | – |
| ELY | Exit | CALLAWAY GOLF COMPANYequity | $0 | – | -200,000 | -100.0% | -2.26% | – |
| STRM | Exit | STREAMLINE HEALTH SOLUTIONSequity | $0 | – | -4,930,882 | -100.0% | -3.02% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCequity | $0 | – | -90,000 | -100.0% | -3.27% | – |
| HUM | Exit | HUMANA INCequity | $0 | – | -20,000 | -100.0% | -3.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.